Logo image of IDEX

IDEANOMICS INC (IDEX) Stock Fundamental Analysis

NASDAQ:IDEX - Nasdaq - US45166V2051 - Common Stock - Currency: USD

0.88  -0.04 (-4.36%)

After market: 0.634 -0.25 (-27.95%)

Fundamental Rating

0

We assign a fundamental rating of 0 out of 10 to IDEX. IDEX was compared to 128 industry peers in the Machinery industry. IDEX may be in some trouble as it scores bad on both profitability and health. IDEX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year IDEX has reported negative net income.
IDEX had a negative operating cash flow in the past year.
In the past 5 years IDEX always reported negative net income.
IDEX had a negative operating cash flow in each of the past 5 years.
IDEX Yearly Net Income VS EBIT VS OCF VS FCFIDEX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -50M -100M -150M -200M -250M

1.2 Ratios

IDEX's Return On Assets of -191.90% is on the low side compared to the rest of the industry. IDEX is outperformed by 97.69% of its industry peers.
Industry RankSector Rank
ROA -191.9%
ROE N/A
ROIC N/A
ROA(3y)-117.79%
ROA(5y)-94.59%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IDEX Yearly ROA, ROE, ROICIDEX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500 1K 1.5K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for IDEX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
IDEX Yearly Profit, Operating, Gross MarginsIDEX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -500 -1K

More info and screens

0

2. Health

2.1 Basic Checks

IDEX does not have a ROIC to compare to the WACC, probably because it is not profitable.
IDEX has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, IDEX has more shares outstanding
IDEX has a worse debt/assets ratio than last year.
IDEX Yearly Shares OutstandingIDEX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
IDEX Yearly Total Debt VS Total AssetsIDEX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

Based on the Altman-Z score of -16.65, we must say that IDEX is in the distress zone and has some risk of bankruptcy.
IDEX has a Altman-Z score of -16.65. This is amonst the worse of the industry: IDEX underperforms 96.92% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -16.65
ROIC/WACCN/A
WACC6.47%
IDEX Yearly LT Debt VS Equity VS FCFIDEX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M

2.3 Liquidity

IDEX has a Current Ratio of 0.28. This is a bad value and indicates that IDEX is not financially healthy enough and could expect problems in meeting its short term obligations.
IDEX has a Current ratio of 0.28. This is amonst the worse of the industry: IDEX underperforms 98.46% of its industry peers.
A Quick Ratio of 0.11 indicates that IDEX may have some problems paying its short term obligations.
IDEX has a Quick ratio of 0.11. This is amonst the worse of the industry: IDEX underperforms 97.69% of its industry peers.
Industry RankSector Rank
Current Ratio 0.28
Quick Ratio 0.11
IDEX Yearly Current Assets VS Current LiabilitesIDEX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M

More info and screens

0

3. Growth

3.1 Past

IDEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 64.75%, which is quite impressive.
The Revenue for IDEX has decreased by -65.32% in the past year. This is quite bad
Measured over the past years, IDEX shows a very negative growth in Revenue. The Revenue has been decreasing by -47.23% on average per year.
EPS 1Y (TTM)64.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.11%
Revenue 1Y (TTM)-65.32%
Revenue growth 3Y-16.76%
Revenue growth 5Y-47.23%
Sales Q2Q%-77.68%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y58.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year74.39%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IDEX Yearly Revenue VS EstimatesIDEX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
IDEX Yearly EPS VS EstimatesIDEX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2020 2021 2022 2023 2024 -20 -40 -60

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for IDEX. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for IDEX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IDEX Price Earnings VS Forward Price EarningsIDEX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
IDEX Per share dataIDEX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15 -20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

IDEX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

IDEANOMICS INC

NASDAQ:IDEX (7/10/2024, 8:07:35 PM)

After market: 0.634 -0.25 (-27.95%)

0.88

-0.04 (-4.36%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)03-14 2024-03-14/amc
Earnings (Next)08-02 2024-08-02
Inst Owners0.12%
Inst Owner Change0%
Ins Owners52.88%
Ins Owner Change0%
Market Cap17.66M
Analysts43.33
Price Target1.02 (15.91%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-98.19%
Min Revenue beat(2)-99.37%
Max Revenue beat(2)-97.01%
Revenue beat(4)0
Avg Revenue beat(4)-93.6%
Min Revenue beat(4)-99.37%
Max Revenue beat(4)-87.75%
Revenue beat(8)0
Avg Revenue beat(8)-83.55%
Revenue beat(12)1
Avg Revenue beat(12)-58.6%
Revenue beat(16)1
Avg Revenue beat(16)-44.32%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.96
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-21.43
EYN/A
EPS(NY)-0.1
Fwd EYN/A
FCF(TTM)-2.62
FCFYN/A
OCF(TTM)-2.62
OCFYN/A
SpS0.92
BVpS-0.71
TBVpS-3.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -191.9%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-117.79%
ROA(5y)-94.59%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.28
Quick Ratio 0.11
Altman-Z -16.65
F-Score2
WACC6.47%
ROIC/WACCN/A
Cap/Depr(3y)67.58%
Cap/Depr(5y)57.59%
Cap/Sales(3y)4.51%
Cap/Sales(5y)3.66%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%90.11%
EPS Next Y58.33%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-65.32%
Revenue growth 3Y-16.76%
Revenue growth 5Y-47.23%
Sales Q2Q%-77.68%
Revenue Next Year74.39%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y30.96%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year144.14%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y61.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y59.49%
OCF growth 3YN/A
OCF growth 5YN/A